Huda Y. Zoghbi, a Director at Regeneron Pharmaceuticals, Inc. (REGN), executed a significant sale of company stock on November 5, 2026. Zoghbi sold 6,939 shares at an average price of $970.42 per share, resulting in a total transaction value of approximately $6.73 million.
This transaction follows other notable insider selling activity at Regeneron. On November 3, 2026, Zoghbi also sold 500 shares for approximately $485,530. Additionally, Joseph J. LaRosa and George L. Sing, also associated with the company, reported stock sales earlier in November.
Insider sales can be motivated by a variety of factors, including personal financial planning, diversification of investment portfolios, or adherence to pre-established trading plans. Such sales do not necessarily indicate a negative view of the company's future performance.